Table 1

Demographic and Clinical Characterization of the CPP and Control Groups.

Control

CPP

p


Number of subjects

48

108

---

Age, years (mean ± SD)

31.8 ± 8.7

35.3 ± 8.6

ns

BMI, kg/m2 (mean ± SD)

26.4 ± 4.7

26.0 ± 4.8

ns

No. of gestations (median, range) range)

2, 0–8

2, 0–6

ns

Abortion % (n)

14.6 (7/48)

20.7 (22/106)

ns

Episiotomy % (n)

29.2 (14/48)

35.2 (38/108)

ns

Cesarean section %, (n)

41.7 (20/48)

35.2 (38/108)

ns

Stable relationship % (n)

66.7 (32/48)

76.8 (83/108)

ns

Duration of symptoms (months) mean ±

---

60.9 ± 6.4

---

VAS (mean ± SD)

---

66.8 ± 2.1

---

McGill (mean ± SD)

---

28.7 ± 2

---

BDI (median, range)

8, 0–28

16, 3–42

<0.01

Dysmenorrhea % (n)

12.5 (6/48)

62 (67/108)

<0.01

Dyspareunia* % (n)

8.3 (4/48)

49.1 (53/108)

<0.01

Intestinal symptoms % (n)

4.2 (2/48)

41.7 (45/108)

<0.01

Urinary symptoms % (n)

12.5 (6/48)

47.2 (51/108)

<0.01


Notes- SD: standard deviation; BMI: body mass index; CPP: chronic pelvic pain; VAS: Visual Analogue Scale; BDI: Beck Depression Inventory.

*Considering only moderate or intense symptoms. If we also consider mild symptoms, control: 20.8% (10/48) × CPP: 75.9% (82/108).

Montenegro et al. BMC Musculoskeletal Disorders 2009 10:82   doi:10.1186/1471-2474-10-82

Open Data